Theriva Biologics, Inc.

Historical 13F Holders

Symbol
TOVX
CUSIP
87164U508
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 87164U508 since 12/18/2024, newest first.

Filer % of Class Filed
Jeffrey Matthew Gryga Irrevocable Trust 13G
7.7% 11/10/2025
Event 10/24/2025
Empery Asset Management, LP 13G/A Amendment 1
4.99% 10/21/2025
Event 9/30/2025
Empery Asset Management, LP 13G
10.0% 7/31/2025
Event 6/30/2025
CVI Investments, Inc. 13G/A Amendment 1
4.9% 2/7/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 26 1.98 M $496 k
2026 Q1 22 1.97 M $385 k
2025 Q4 21 1.30 M $272 k
2025 Q3 20 437 k $177 k
2025 Q2 18 291 k $126 k
2025 Q1 11 191 k $210 k
2024 Q4 11 34.5 k $60.3 k
2024 Q3 19 492 k $679 k